Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway
- 28 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 333, 118498
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of actionBiomedicine & Pharmacotherapy, 2024
- Linderae Radix Ameliorates Cognitive Dysfunction by Inhibiting Neuroinflammation and Synaptic Damage in Alzheimer’s Disease ModelsMolecular Neurobiology, 2023
- Signal pathways in the treatment of Alzheimer’s disease with traditional Chinese medicineBiomedicine & Pharmacotherapy, 2022
- The naturally‐derived alkaloids as a potential treatment for COVID‐19: A scoping reviewPhytotherapy Research, 2022
- Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic PotentialNeurochemical Research, 2021
- Alzheimer's & Dementia: The Journal of the Alzheimer's AssociationAlzheimer's & Dementia, 2020
- The Role of PI3K/Akt and ERK in Neurodegenerative DisordersNeurotoxicity Research, 2019
- Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse modelCancer Letters, 2019
- Glycogen Synthase Kinase 32017
- Total alkaloids from Radix Linderae prevent the production of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 cells by suppressing NF-κB and MAPKs activationCytokine, 2009